| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new murine model of Barth syndrome neutropenia links TAFAZZIN deficiency to increased ER stress-induced apoptosis
|
Sohn, Jihee
|
|
|
6 |
8 |
p. 2557-2577
|
artikel
|
| 2 |
A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment
|
Jensen, Paw
|
|
|
6 |
8 |
p. 2549-2556
|
artikel
|
| 3 |
Bornhauser B, Cario G, Rinaldi A, et al. The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL. Blood Adv. 2020;4(17):4052-4064.
|
|
|
|
6 |
8 |
p. 2700
|
artikel
|
| 4 |
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
|
Lakhotia, Rahul
|
|
|
6 |
8 |
p. 2667-2680
|
artikel
|
| 5 |
Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML
|
Ramaswamy, Kavitha
|
|
|
6 |
8 |
p. 2688-2694
|
artikel
|
| 6 |
Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS report
|
Balas, Nora
|
|
|
6 |
8 |
p. 2471-2479
|
artikel
|
| 7 |
CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma
|
Guo, Yelei
|
|
|
6 |
8 |
p. 2695-2699
|
artikel
|
| 8 |
Cyclophosphamide induces durable molecular and clinical responses in patients with relapsed T-LGL leukemia
|
Braunstein, Zachary
|
|
|
6 |
8 |
p. 2685-2687
|
artikel
|
| 9 |
Development of BRAFV600E -positive acute myeloid leukemia in a patient on long-term dabrafenib for multisystem LCH
|
Salek, Marta
|
|
|
6 |
8 |
p. 2681-2684
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
6 |
8 |
p. i
|
artikel
|
| 11 |
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol
|
Buccisano, Francesco
|
|
|
6 |
8 |
p. 2510-2516
|
artikel
|
| 12 |
Eshel A, Sharon I, Nagler A, et al. Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis. Blood Adv. 2022;6(2):568-573.
|
|
|
|
6 |
8 |
p. 2578-2580
|
artikel
|
| 13 |
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning
|
Iwasaki, Makoto
|
|
|
6 |
8 |
p. 2618-2627
|
artikel
|
| 14 |
Ferrari N, Ward G, Gewinner C, et al. Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma. Blood Adv. 2021;5(20):4003-4016.
|
|
|
|
6 |
8 |
p. 2548
|
artikel
|
| 15 |
Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation
|
Martin, Paul J.
|
|
|
6 |
8 |
p. 2608-2617
|
artikel
|
| 16 |
Genome-wide CRISPR/Cas9 screening identifies determinant of panobinostat sensitivity in acute lymphoblastic leukemia
|
Jiang, Chuang
|
|
|
6 |
8 |
p. 2496-2509
|
artikel
|
| 17 |
Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study
|
Joelsson, Joel
|
|
|
6 |
8 |
p. 2657-2666
|
artikel
|
| 18 |
Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma
|
Maziarz, Richard T.
|
|
|
6 |
8 |
p. 2536-2547
|
artikel
|
| 19 |
Lymphocyte cytosolic protein 1 (L-plastin) I232F mutation impairs granulocytic proliferation and causes neutropenia
|
Mahat, Upendra
|
|
|
6 |
8 |
p. 2581-2594
|
artikel
|
| 20 |
Minor PNH clones do not distinguish inherited bone marrow failure syndromes from immune-mediated aplastic anemia
|
Narita, Atsushi
|
|
|
6 |
8 |
p. 2517-2519
|
artikel
|
| 21 |
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT
|
Kinoshita, Hannah
|
|
|
6 |
8 |
p. 2520-2534
|
artikel
|
| 22 |
Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice
|
Lundgren, Taran S.
|
|
|
6 |
8 |
p. 2628-2645
|
artikel
|
| 23 |
Platelet SHARPIN regulates platelet adhesion and inflammatory responses through associations with αIIbβ3 and LUBAC
|
Kasirer-Friede, Ana
|
|
|
6 |
8 |
p. 2595-2607
|
artikel
|
| 24 |
Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics
|
Migdady, Yazan
|
|
|
6 |
8 |
p. 2707-2721
|
artikel
|
| 25 |
Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma
|
Mohan, Meera
|
|
|
6 |
8 |
p. 2466-2470
|
artikel
|
| 26 |
Singh A, Brandow AM, Panepinto JA. COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals. Blood Adv. 2021;5(7):1915-1921.
|
|
|
|
6 |
8 |
p. 2535
|
artikel
|
| 27 |
SIPA in 10 milliseconds: VWF tentacles agglomerate and capture platelets under high shear
|
Liu, Zixiang Leonardo
|
|
|
6 |
8 |
p. 2453-2465
|
artikel
|
| 28 |
SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma
|
Yamamoto, Tomofumi
|
|
|
6 |
8 |
p. 2480-2495
|
artikel
|
| 29 |
The CLL comorbidity index in a population-based cohort: a tool for clinical care and research
|
Rotbain, Emelie C.
|
|
|
6 |
8 |
p. 2701-2706
|
artikel
|
| 30 |
The TAp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemia
|
Laidou, Stamatia
|
|
|
6 |
8 |
p. 2646-2656
|
artikel
|
Tijdschrift beschrijving